Exercise Intervention and Immunodeficiency
Part of paid clinical trials in Milford, Connecticut.
- Sponsor
- Yale University
- Study ID
- NCT07698197
- Status
- Recruiting
Conditions
- Primary Antibody Deficiency Disorders
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- App-based exercise intervention — BEHAVIORAL12 week structured moderate-intensity exercise intervention delivered via a mobile application
Study Details
The purpose of this study is to assess if a 12-week exercise program is safe, practical, and acceptable for adults with primary antibody deficiencies. It also looks at whether the program can improve the quality of life and help the immune system work better.
Key Dates
- First listed
- Jul 13, 2026
- Start date
- Jul 17, 2026
- Status verified
- Jul 2026
- Primary completion
- Jul 31, 2027
- Completion
- Jul 31, 2027
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: App-based exercise intervention12-week, app-based exercise intervention in adults with primary antibody deficiencies with completion of survey procedures and collection of clinical and laboratory data
Primary Outcome Measure
Recruitment rate [ Time Frame: Day 1 ]
Central Contacts
- Ryan Steele, DO, MSc203-785-7092
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Bridgeport Hospital | Milford | Connecticut | 06460 | - |
| Yale New Haven Health | North Haven | Connecticut | 06473 | - |